Framework Venture Partners

Framework Venture Partners is a Toronto-headquartered Canadian venture firm focused on B2B SaaS and AI investments, operating across Canada and the United States. This profile is included for catalog completeness, and founders should know that Framework Venture Partners is not a healthcare investor and is structurally unlikely to be relevant for healthcare AI founders building clinical, therapeutic, diagnostic, or care delivery products. The firm is also distinct from US Framework Ventures, the crypto-focused fund, and the two should not be confused.

The thesis is concentrated on B2B SaaS and AI applied to enterprise software, with explicit AI focus running through most recent investment activity. The firm’s healthcare sub-vertical list in the source data is empty, which accurately reflects its portfolio orientation toward horizontal enterprise software, vertical SaaS in non-healthcare industries, and AI infrastructure rather than clinical or life sciences applications. The firm’s notes explicitly identify it as Toronto B2B SaaS and AI rather than as a healthcare-relevant investor, which is consistent with portfolio activity. Founders building AI-native enterprise software for sectors like financial services, retail, manufacturing, professional services, or horizontal infrastructure will find genuine thematic alignment. Founders building clinical AI, healthcare software, biotech tools, or any product whose primary customers are healthcare providers, payers, or life sciences companies will find essentially no thematic overlap.

Portfolio activity reflects the B2B SaaS and AI focus across Canadian and US enterprise software companies. Specific portfolio company names are not provided in the source data, so founders evaluating fit should review the firm’s website at framework.vc directly to understand current investment activity. The firm’s strategic value to portfolio companies sits in operational support for scaling B2B SaaS go-to-market motions, including enterprise sales, customer success, and the playbooks needed to grow from early traction to repeatable revenue. That value translates poorly into healthcare-specific go-to-market challenges, where regulatory, reimbursement, and clinical evidence considerations dominate the path to scale in ways that horizontal SaaS playbooks cannot address.

Framework writes $5M to $25M checks across Series A and Series B, which positions it as an institutional lead or co-lead for the first or second institutional round rather than as a seed or growth-stage participant. Geographic focus is Canada and the United States, with primary deal flow concentrated in North American B2B SaaS and AI companies. The firm participates as a lead or co-lead financial investor rather than as a strategic CVC, which means engagement processes are conventional venture diligence focused on commercial fundamentals and team quality. Founders raising sub-$5M seed rounds or growth rounds above $25M should look to other firms whose check sizes match their needs.

The team is structured as a conventional Canadian venture firm with partners whose backgrounds span enterprise software operating experience, venture investing, and B2B go-to-market expertise. Specific partner names are not provided in the source data, so founders should engage through the firm’s main channels and expect routing to the partner whose expertise aligns with the relevant sector or business model. The team’s value to portfolio companies is operational and pattern-recognition driven, with the firm’s experience scaling B2B SaaS companies in the Canadian and US markets translating into hands-on support around sales, customer success, and product strategy.

The approach is conventional B2B SaaS and AI venture investing with operational engagement. Framework Venture Partners is willing to lead or co-lead institutional rounds, expects clear unit economics and credible enterprise sales motions, and brings a hands-on partner model rather than a hands-off financial-only approach. The firm has built a reputation as a serious Canadian venture investor in the B2B SaaS and AI space, which is genuinely valuable for founders building in that thematic area but largely irrelevant for healthcare-focused companies.

What healthcare AI founders should know is direct: this fund is not for you. The catalog inclusion reflects Framework’s general AI investing activity rather than any healthcare relevance, and the firm’s notes explicitly classify it as not healthcare. Founders building horizontal B2B SaaS or AI infrastructure for non-healthcare enterprise customers should treat Framework Venture Partners as a serious Canadian venture investor worth engaging at Series A or Series B. Founders building clinical AI, healthcare software, biotech platforms, life sciences tools, or any product whose primary customers are healthcare providers, payers, or patients should focus their fundraising effort on healthcare-specialist and healthcare-active generalist investors with actual healthcare conviction rather than spending cycles on a fund whose portfolio and operational expertise are oriented away from the sector.